Trademark Overview
On Monday, December 22, 2025, a trademark application was filed for SISAQOL with the United States Patent and Trademark Office. The USPTO has given the SISAQOL trademark a serial number of 99560444. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Sunday, July 19, 2026. This trademark is owned by ORGANISATION EUROPEENNE POUR LA RECHERCHE ET LE TRAITEMENT DU CANCER - EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER, in short EORTC. The SISAQOL trademark is filed in the Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Arranging of educational conferences, workshops and training sessions in the fields of patient-reported outcomes (PROs) and health-related quality of life (HRQOL); providing online non-downloadable electronic publications in the form of books, journals, articles, reports, educational materials, transcripts and graphs in the fields of patient-reported outcomes (PROs) and health-related quality of life (HRQOL); providing training in the fields of reporting of outcomes in clinical research and healthcare practice, and in the fields of methodology and implementation of patient-reported outcomes (PROs) relating to the reporting of outcomes in clinical research and healthcare practice; providing recommendations on literature relating to the reporting of outcomes in clinical research and healthcare practice, and in the fields of methodology and implementation of patient-reported outcomes (PROs) relating to the reporting of outcomes in clinical research and healthcare practice
Medical consultancy and advisory services relating to patient-reported outcomes (PROs), including their use in clinical practice and treatment evaluation; Providing medical information related to PROs; Providing medical information and guidance to healthcare professionals on interpreting and applying patient-reported outcomes (PROs) data in oncology and other therapeutic areas; Medical consultancy in the field of patient-centered care and medical outcomes assessment; Medical consultancy relating to the support of personalized treatment planning through the structured use of patient-reported outcomes (PROs) frameworks
Scientific and technological services, namely, the development and testing of methodologies for the design, analysis, interpretation, and presentation of patient-reported outcomes (PROs) in clinical trials or other medical research; Research and design of standardized data analysis frameworks in oncology and other therapeutic areas; Providing scientific information, and clinical research support and related consulting services; Development of software tools for the implementation of patient-reported outcomes (PROs) in health-related research; hosting and maintenance of online platforms and non-downloadable software for others in the field of patient-reported outcomes (PROs) methodology implementation
